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Impaired Innate Host Defense Causes Susceptibility
to Respiratory Virus Infections in Cystic Fibrosis
children, 39% of CF children in the first year of life are
hospitalized with respiratory compromise related to re-
spiratory virus infection. Furthermore, individuals hospi-
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Roger Slee,2 Bryan R.G. Williams,2 Joseph Pilewski,4
S. Jaharul Haque,1,2 and Serpil C. Erzurum1,2,* talized with respiratory symptoms during infancy are six
times more likely to acquire Pseudomonas aeruginosa1Department of Pulmonary and Critical Care Medicine
2 Department of Cancer Biology during early childhood (Armstrong et al., 1998). Studies
show a relationship between viral respiratory tract infec-3 Department of Virology
Lerner Research Institute tion with respiratory syncytial virus, parainfluenza virus,
and influenza virus and pulmonary exacerbation andCleveland Clinic Foundation
Cleveland, Ohio 44195 disease progression in CF children (Hiatt et al., 1999;
Hordvik et al., 1989; Petersen et al., 1981; Wang et al.,4 Departments of Medicine, and Cell Biology
and Physiology 1984). Although CF patients have no higher incidence
of viral infection, severity of viral infection is amplified.University of Pittsburgh
Pittsburgh, Pennsylvania 15261 The innate antiviral response of human cells involves
distinct cellular programs (Iordanov et al., 2001). In the
presence of dsRNA, a common viral intermediate, 2,
5 oligoadenylate synthetase (2, 5 OAS), and dsRNA-Summary
dependent protein kinase (PKR) promote inhibition of
host cell protein synthesis by activating RNase L toViral infection is the primary cause of respiratory mor-
degrade viral and cellular RNA and by phosphorylatingbidity in cystic fibrosis (CF) infants. Here, we identify
the  subunit of translation initiation factor, eIF2, tothat host factors allow increased virus replication and
block its recycling from an inactive form, respectively.cytokine production, providing a mechanism for un-
This prevents viral replication, eventually leading to thederstanding the severity of virus disease in CF. In-
self-elimination of the infected cell via apoptosis. Thiscreased virus is due to lack of nitric oxide synthase 2
program is probably most efficient for viral infections(NOS2) and 2, 5 oligoadenylate synthetase (OAS) 1
that are initiated by a small number of infected cellsinduction in response to virus or IFN. This can be
at a local site of virus entry. A second program is theattributed to impairment of activation of signal trans-
production of antiviral interferons (IFN) by mucosal cellsducer and activator of transcription (STAT)1, a funda-
and serves the purpose of preparing adjacent naive cellsmental component to antiviral defense. NO donor or
for resistence to viral invasion. This program requiresNOS2 overexpression provides protection from virus
survival of infected cells and expression of antiapoptoticinfection in CF, suggesting that NO is sufficient for
genes through activation of nuclear factor-B (NF-B)antiviral host defense in the human airway and is one
transcription factor. NF-B and interferon regulatorystrategy for antiviral therapy in CF children.
factors (IRF) 3 and 7 are required for production of type
1 interferons (Grandvaux et al., 2002). Subsequently, IFNIntroduction
induces antiviral pathways including PKR, 2, 5 OAS/
RNase L system, and Mx proteins (Samuel, 1991; StarkCystic fibrosis (CF) is the most common lethal genetic
et al., 1998). Mx proteins are IFN-inducible, high-abun-disorder among Caucasians, affecting an estimated
dance GTPases which interfere with viral replication,30,000 persons in the US (Cystic Fibrosis Foundation,
impairing the growth of negative-strand RNA viruses at2000). The gene responsible for CF (Kerem et al., 1989;
the level of viral transcription and other steps (Stark etRiordan et al., 1989; Rommens et al., 1989) produces the
al., 1998). dsRNA or IFN- are also potent activators ofcystic fibrosis transmembrane conductance regulator
nitric oxide synthase 2 (NOS2)- and nitric oxide (NO)-(CFTR), a polypeptide of 1480 amino acids with molecu-
dependent antiviral pathways. High-level NO synthesislar mass of 168 kDa, and function of a cAMP-dependent
results in a large variety of reactive products, which canCl channel (Anderson et al., 1991; Sheppard and Welsh,
inhibit viral replication by modifying a number of target1999). CF is characterized by chronic lung infections
molecules essential for replication (Biron, 1999). STAT1,with bacteria, mostly Pseudomonas aeruginosa, intense
a member of a family of proteins that transduce signalsneutrophil-dominated airway inflammation, and pro-
from cell surface receptors to the nucleus and activategressive lung disease, which is the major cause of mor-
transcription by binding directly to regulatory DNA ele-bidity and mortality. Bacterial colonization of CF lung is
ments, is essential for host antiviral defense. IFN- andusually established in the first decade of life (Rosenfeld
IFN- lead to phosphorylation of STAT1 and binding toand Ramsey, 1992). Little is known about the factors
unique elements in a number of IFN-stimulated genesassociated with initial colonization in CF lung, but viral
(ISGs), activating transcription (Haque and Williams,infections predispose CF lung to bacterial colonization.
1998). Although many antiviral genes are induced orAlthough chronic bacterial infection occurs in older CF
activated in direct response to viral dsRNA, fundamental
components of antiviral defense are activation of PKR,*Correspondence: erzurus@ccf.org
2, 5 OAS, and NOS2 via the IFN/STAT1 pathways. In5Present address: Belfer Gene Therapy Core Facility, Weill Medical
College of Cornell University, New York, NY 10021. support of this, STAT1-deficient mice, which display
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Figure 1. Increased HPIV3 Replication in CF Cells
(A) Phase contrast picture of NL and CF cells, uninfected (upper panels) or 24 hr after HPIV3 infection (middle panels) and immunoflurescence
staining for HPIV3 NP 24 hr postinfection (lower panels) (n  3). Bars, 100 m.
(B) Equal amounts (20 g) of 35S-methionine-labeled new protein synthesized in NL and CF cells were immunoprecipitated by HPIV3 anti-RNP
antibody and loaded in each lane (n  3).
a complete lack of responsiveness to IFN, are highly Immunofluoresent staining for HPIV3 N-protein (NP) re-
vealed greater size and number of syncytia containingsensitive to infection by virus (Durbin et al., 1996; Meraz
et al., 1996). virus in CF cells (lower panel). To confirm that the NP
present in the cell lysate was from viral replication andIn this context, we hypothesized that CF airway epi-
thelial cells may be less effective in eliminating viral not from added virus, new protein synthesized was eval-
uated by 35S-methionine incorporation followed by SDSinfection due to an impairment of the antiviral host de-
fense mechanisms in CF lung. Here, we show that CF polyacrylamide gel electrophoresis of cell lysates immu-
noprecipitated with anti-RNP antibody which recog-airway epithelial cells allow increased replication of
parainfluenza virus and an increased production of pro- nizes HPIV3 NP. NP was detected at2-fold higher level
in CF than NL (Figure 1B).inflammatory cytokines. Investigation of the innate and
interferon (IFN)-mediated antiviral pathways reveals that
the antiviral pathway of nitric oxide synthesis is absent IFN Pretreatment Protects CF Cells from Virus
First identified because of their ability to interfere within CF. Furthermore, upregulation of 2, 5 OAS1 does
not occur in CF cells in response to IFN or dsRNA. This virus replication, IFNs are fundamental in host antiviral
defense (Biron, 1999; Briscoe et al., 1996; Durbin etcan be attributed to impaired STAT1 activation, which
may be a central mechanism responsible for the defi- al., 1996; Grandvaux et al., 2002; Isaacs et al., 1957;
Karaghiosoff et al., 2000; Karupiah et al., 1993; Samuel,ciencies in CF antiviral host defense.
1991; Stark et al., 1998). To investigate IFN antiviral
effects in CF, CF cells were pretreated with 1000 U/mlResults
IFN-, IFN-, or no cytokine for 24 hr, and then infected
with HPIV3 (0.1 moi). Syncytia formation was prevalentIncreased Viral Replication in CF
CF and normal (NL) human airway epithelial cells (HAEC) in untreated CF cells (Figure 2A, upper-right panel), but
pretreatment with IFN- or IFN- prevented viral syncy-were infected with human parainfluenza virus 3 (HPIV3)
(0.1 moi) and syncytia (cell-cell fusion) formation evalu- tia formation (Figure 2A, lower panels). Evaluation of
HPIV3 N-mRNA expression revealed that more virusated (Figure 1A). Cell-cell fusion was increased in CF
cells compared to NL 24 hr after infection (middle panel). N-mRNA was formed in infected CF than in NL cells,
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Figure 2. IFN Pretreatment Protects CF Cells from HPIV3 Infection
(A) Phase contrast pictures of CF cells, untreated (upper-left panel), infected with HPIV3 (upper-right panel), or pretreated with IFN- (lower-
left panel) or IFN- (lower-right panel) 24 hr before HPIV3 infection (n  2). Bars, 100 m.
(B) Infectious viral particles in media overlying cells untreated or pretreated with IFN- (1000 U/ml) or IFN- (1000 U/ml) measured by plaque
assay [plaque forming units (pfu)/ml  103] after HPIV3 infection (0.1 moi). Infectious viral particles are higher titer in media overlying CF cells
(n  5) than NL (n  3) [p  0.015].
and IFN- or IFN- pretreatment significantly reduced induce MxA (Figure 3A). MxA was produced at later
times after HPIV3 infection as compared to IFN- stimu-the N-mRNA in both NL and CF cells (data not shown).
lation (data not shown). IFN- is synthesized by lungMedia overlying cells were evaluated for infectious
epithelial cells after viral infection (Gao et al., 1999), andHPIV3 particles by plaque assay. CF produced 6-fold
virus-induced MxA expression is likely a consequencemore infectious HPIV3 as compared to NL (CF: 53 	 15,
of IFN- (Pavlovic et al., 1992; Ronni et al., 1997). Similarrange 3070, n  5; NL: 8 	 2, range 610, n  3 [103
levels of IFN-were produced by CF and NL in responsepfu/ml]). IFN- and IFN- pretreatment reduced virus in
to virus, reaching peak levels in media overlying cellsCF to NL levels (Figure 2B). Innate antiviral pathways in
by 6 hr postinfection (data not shown).NL cells appeared effective in eliminating viral replica-
Western analyses for IRF-1, PKR, RNase L, and 2, 5tion, but IFN pretreatment reduced viral load by 1.5-
OAS1 were performed with cell lysates collected at 4,fold. IFN- and IFN- pretreatment reduced virus in CF
16, and 24 hr after stimulation with virus mimic, dsRNA,by 7- and 5-fold, respectively (p
 0.05, student’s t test).
or IFN-. PKR and IRF-1 were induced by IFN- andIncreased viral replication may result in an increase
polyIC in both NL and CF. RNase L did not changein proinflammatory cytokine production and contribute
before or after stimulation but was present in both cellto severity of virus infection in vivo (Matsukura et al.,
types. Although NL cells increased 2, 5 OAS1 after
1996; Zhu et al., 1996). Thus, cytokine production by
stimulation, CF cells failed to upregulate expression of
cells was evaluated. Supernatant from CF cells 24 hr
2, 5 OAS1 (Figure 3B). Viral induction of NOS2 in CF
after HPIV3 infection had higher IL-6 and IL-8 compared and NL was assessed 24 hr after HPIV3 infection (0, 0.2,
to NL, although baseline levels were similar [(baseline: 0.4, 1.0 moi). NL showed a dose-dependent induction
IL-6 pg/ml, CF 13 	 1, NL 12 	 2; IL-8 pg/ml, CF 195 	 of NOS2 by HPIV3, but CF had no detectable NOS2.
87, NL 164 	 30; n  3, p  0.05 CF versus NL), (24 hr Expression of MxA confirmed the presence of viral infec-
postinfection: IL-6 pg/ml, CF 2568 	 1996, NL 208 	 tion (Figure 3C). Reverse transcription of RNA and poly-
62; IL-8 pg/ml, CF 11920 	 8606, NL 2822 	 245, n  merase chain reaction of cDNA (RT-PCR) analysis of
3, p 
 0.05, 24 hr comparison, CF versus NL, Mann- NOS2 mRNA in CF and NL confirmed lack of NOS2
Whitney test)]. induction in CF in response to HPIV3 (data not shown).
Early in virus infection, host defenses including NOS2
may be induced by dsRNA through PKR signaling path-
Expression of Antiviral Proteins in CF ways, independent of IFN-, in NL cells (Uetani et al.,
CF and NL cells infected with HPIV3 (0.1 moi) or treated 2000). However, by 24 hr after infection, large amounts
with IFN- for 24 hr expressed MxA. IFN- induced of IFN- are produced which lead to activation of numer-
ous downstream target genes. Specifically, IFN- is ahigher MxA compared to HPIV3, while IFN- did not
Immunity
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Figure 3. Impaired Antiviral Pathways in CF Cells
(A) Western analysis of MxA in CF and NL cells, untreated, infected with HPIV3 (0.1 moi), or stimulated by IFN- (1000 U/ml) or IFN- (1000
U/ml) for 24 hr (n  2).
(B) Western analysis of PKR, IRF-1, RNase L, and 2, 5- OAS1 in CF and NL cells, untreated, or treated with IFN- (1000 U/ml), polyIC (100
ng/ml), or by mixture of IFN- and polyIC (n  3).
(C) Western analysis for NOS2 and MxA in NL and CF cells, uninfected and infected with HPIV3 (n  2).
(D) Northern analysis for NOS2 in total RNA (4 g/lane) from CF or NL cells 24 hr after IFN- stimulation. Total RNA (5 g/lane) from A549 cells 8
hr after stimulation with 103 U/ml IFN-, 0.5 ng/ml IL-1, and 10 ng/ml TNF- (cytokine mixture, CK) was used as positive control (n  2).
(E) Western analysis of NOS2 protein in cell lysate (50 g total protein/lane) from NL or CF cells 24 hr after IFN- stimulation (n  3).
potent inducer of NOS2 gene expression in normal hu- Similar IFN Response in CF and NL Cells
Based upon findings of defective induction of two antivi-man airway cells (Guo et al., 1997; Uetani et al., 2000).
Here, Northern analysis of NOS2 expression revealed ral pathways, we expanded evaluation of the IFN re-
sponse in CF. We compared gene expression profilesthat NL cells expressed NOS2 mRNA upon IFN- expo-
sure, while CF cells did not (Figure 3D). Western analysis in CF and NL at baseline (Figure 4A) and 8 hr after IFN
(Figures 4B and 4C) by a custom-constructed ISG/AU/of proteins extracted at different time points after IFN-
stimulation showed that NL produced NOS2 protein as dsRNA cDNA microarray, which contains 2921 genes
specific for viral and IFN responses. IFN responses wereearly as 16 hr, while CF had no detectable NOS2 (Figure
3E). We also tested induction of NOS2 by polyIC, and similar between CF and NL with only 0.9% and 0.5%
difference in IFN-- and IFN--induced changes in genecombinations of cytokines (IFN-, IL-1, TNF-) in repli-
cate experiments (n  3). NOS2 was not induced in CF expression (correlation of CF to NL response: IFN-R2
0.931; IFN- R2  0.940). IFN- induced 81 genes andcells by any combination of stimuli (data not shown).
Antiviral Host Defense and CF
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Figure 4. Gene Expression Profile of CF and NL Cells
(A) Baseline gene expression of CF cells compared to NL. (B) Gene expression 8 hr after IFN- or (C) IFN- treatment in CF cells.
repressed 68 genes; IFN- induced 27 genes and re- inhibitor of IRF-1. Both genes are key to antiviral defense
and specifically to NOS2 induction (Briscoe et al., 1996;pressed 33 genes. This similarity of CF response to NL
accounts for the effectiveness of IFN pretreatment in Kamijo et al., 1994; Nelson et al., 1993). The 2, 5 OAS1
was also lower in CF at baseline, confirming the Westerninhibiting virus replication in CF cells. On the other hand,
a baseline comparison between CF and NL evaluated by blot analysis (Figure 3B).
ISG/AU/dsRNA microarray identified 226 differentially
expressed genes. In CF cells, 136 genes (4.6% of total Transcription Factors in CF
Further experiments were performed to investigate thegenes) were 2-fold upregulated, and 90 genes (3% of
total genes) were 2-fold downregulated as compared to mechanism of deficiency of antiviral host defense in CF,
and specifically the reduced NOS2 expression in CF. ToNL. This baseline difference was confirmed by tran-
scriptosome analysis on Affymetrix HG-U133A Gene- evaluate signal transduction proteins IRF-1 and NF-B,
which are important to the host antiviral response in-Chips. Table 1 highlights the genes that are different
(1.2-fold change) and relevant to IFN, antiviral effects, cluding NOS2 induction, we treated CF and NL with
IFN- (103 U/ml), tumor necrosis factor- (TNF-) (10 ng/and/or NOS2 induction. Notable findings include de-
creased JAK1, a receptor-associated kinase essential ml), or synthetic dsRNA (polyIC) (100 ng/ml) as a mimic
of virus infection, then the transcription factor activationfor IFN signaling, and increased IRF2, a competitive
Table 1. Gene Expression in CF Cells Relative to NL at Baseline
UniGene Gene Description Ratio CF/NL Genebank
Cytokine-Related Genes
Hs.93913 IL-6: interleukin 6 3.1 NM_000600
Hs.624 IL-8: interleukin 8 2.22 NM_000584
Hs.1722 IL-1 : interleukin 1  3.13 M15329
Hs.285115 IL-13 receptor,  1 1.42 U81380
Hs.25954 IL-13 receptor,  2 2.26 NM_000640
Hs.196384 PTHS2: prostaglandin-endoperoxide synthase 2 2.59 NM_000963
Hs.372783 SOD 2: superoxide dismutase 2, mitochondrial 2.79 X15132
Hs.211600 TNFAIP3: tumor necrosis factor  3 1.51 AI738896
Interferon/Virus-Related Genes
Hs 83795 IRF 2: interferon regulatory factor 2 1.33 NM_002199
Hs 115541 JAK2: Janus kinase 2 2.00 AF001362
Hs.86958 IR-2: interferon receptor 2 2 L41944
Hs.179972 IFI : interferon -induced protein 1.30 NM_018011
Hs.50651 JAK 1: Janus kinase 1 
0.5a
Hs.82396 2, 5 OAS1: 2, 5-oligoadenylate synthetase 1 0.43 NM_002534
Apoptosis
Hs.381231 caspase 8 2 NM_00128
Hs.9216 caspase 7 1.75 NM_001227
Others
Hs.234642 APQ3: aquaporin 3 0.47 NM_004925
Hs.89603 MUC1: mucin 1 0.37 NM_002456
a Ratio from cDNA microarray data. Gene expression level is below detection limit on Affymetrix genechip. All other ratios are from Affymetrix
genechip.
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analyzed in whole-cell extract (WCE) by electrophoretic levels produced by NL cells stimulated with IFN-
[NO2NO3 (M): CF cells  NOS2 transgene, 8.0 	mobility shift assay (EMSA). In contrast to previous re-
ports of reduced IRF-1 expression in whole lungs of CF 1.0; NL cells  IFN-, 9.5 	 0.5]. NO donor compounds
produced higher levels of NO in the media [NO2NO3mice (Kelley and Elmer, 2000; Widdicombe, 2000), IRF-1
was strongly activated by IFN- in both CF and NL. Its (M): SNAP, 50	 20; detaNO, 29	 1]. NO donors SNAP
and deta NONOate, decreased viral load 2.5-fold.activation by TNF- or polyIC was weaker but similar in
CF and NL (Figure 5A). Similarly, NF-B was activated Strikingly, CF cells transfected with NOS2 transgene
(pCCF37) had nearly undetectable infectious virus in theby dsRNA or TNF- in both CF and NL (Figure 5B).
Quantitation of total NF-B (p65 and p50) showed no overlying media (Figure 6B). NOS2 overexpression may
be more efficient than NO donors because NOS2 trans-difference between CF and NL (NF-B relative units:
nonstimulated, CF 990 	 380, NL 1090 	 360; IFN-, gene provides continuous generation of intracellular NO.
CF 970 	 490, NL 1240 	 350; polyIC, CF 2000 	 310,
NL 2670 	 280; TNF- CF 3250 	 140, NL 4130 	 790; Discussion
n  3, all p  0.05).
Activation of STAT1 is essential for NOS2 expression Here, CF airway epithelial cells are shown at the cellular
and the antiviral response (Gao et al., 1997; Guo et al., level to be more susceptible to HPIV3 infection than NL.
1997; Heitmeier et al., 1999). To evaluate STAT1, CF and Increased virus is due to lack of specific antiviral host
NL were exposed to IFN- (103 U/ml) for 30 min, then defense in CF, including NOS2 and 2, 5 OAS 1 which
WCE collected and analyzed by EMSA with 32P-labeled may be attributed to impairment of activation of STAT1.
GAS oligo duplex. CF had lower STAT1 activation com- In support of the biological relevance of 6-fold in-
pared to NL (Figure 5C). Impairment of STAT1 activation crease of virus, murine studies have shown that loss of
was consistent in CF, and 60% of NL (Figure 5D). innate host defenses leads to a moderate increase in
STAT1 is important for not only NOS2 expression, but virus, but significantly more severe clinical outcomes
also for STAT1 itself. To evaluate STAT1 production in (Flodstrom et al., 2001; Kosugi et al., 2002; Noda et al.,
CF, CF and NL cells exposed to IFN- for 24 hr were 2001; Xiang et al., 2002; Zhou et al., 1999). For example,
evaluated by Western blot using rabbit polyclonal anti- even though the increase of virus is modest in organs
STAT1 Ab. 2fTGH and U3A, human fibroblast cell lines of NOS2-deficient (NOS2/) mice with cytomegalovirus
with and without expression of STAT1 (Muller et al., (Noda et al., 2001) or coxsackievirus B4 (Flodstrom et
1993), were used as positive and negative controls for al., 2001) as compared to wild-type, the NOS2 knock-
STAT1 expression. Baseline STAT1 protein in CF was out mice have higher mortality and decreased virus
less than NL, and 24 hr after IFN-, NL expressed more clearance. Likewise, CMV replication is only moderately
STAT1 than CF (Figure 5E). STAT1 protein in CF was enhanced as evidenced by 5-fold increase in viral titers
only 53% of that in NL (CF  1.6 	 0.7, NL  3.0 	 1.3, in mice pretreated with a specific inhibitor of NOS2, but
n  4, p 
 0.05). Furthermore, after IFN- stimulation, this results in viral persistence and latency (Kosugi et
STAT1 in CF was significantly lower than NL (CF 5.1	 al., 2002). Mice triple deficient in Mx, RNase L, and PKR
0.6, NL  10.6 	 2.0, p 
 0.01) (Figure 5F). have increased susceptibility to virus, although viral ti-
ters are not significantly elevated in tissues (Xiang et
al., 2002; Zhou et al., 1999). More severe clinical out-Overexpression of NOS2 or NO Donor Protects CF
from Virus comes with modest increase of virus may occur due
to inherent viral properties and/or altered host cellularPrevious work suggests that loss of NOS2 expression
in cells leads to increased susceptibility to viral infection response (Garcia-Sastre, 2001, 1998; Seo et al., 2002).
For example, virulence may be increased with moder-(Flodstrom et al., 2001; Karupiah et al., 1998; Noda et al.,
2001). Induction of NOS2 prior to infection is associated ately higher titers due to more efficient inhibition of host
antiviral pathways. Conversely, greater activation of sig-with inhibition of viral replication (Reiss and Komatsu,
1998; Sanders, 1999). Since CF cells are unable to ex- naling pathways, such as NF-B, due to increased
dsRNA produced during increased viral replication, maypress NOS2, NOS2 expression construct or NO donors
were used to correct the NO deficiency. We introduced amplify proinflammatory cytokine production (Matsu-
kura et al., 1996; Zhu et al., 1996). In this study, CF cellsNOS2-transgene into CF cells by transfecting the cells
with NOS2 expression plasmid (pCCF37). Control CF released more IL-6 and IL-8 than NL in response to virus.
Higher levels of IL-6 and IL-8, which are involved incells were transfected with reverse sequence NOS2
(R-NOS2) plasmid (pCCF38), or liposome reagent with- neutrophil accumulation and degranulation and contrib-
ute to greater airway inflammation and more severe re-out plasmid, or left untreated. All cells were infected with
HPIV3 (0.5 moi) 24 hr after transfection. Alternatively, two spiratory symptoms with virus (Matsukura et al., 1996;
Zhu et al., 1996). For example, severity of clinical symp-types of NO donors, S-nitroso-N-acetyl penicillamine
(SNAP) or deta NONOate, were added to cells at the time toms with rhinovirus is primarily related to high levels
of IL-6 in nasal secretions (Zhu et al., 1996). CF airways,of viral infection. NOS2 was expressed in CF transfected
with pCCF37 but not in control CF cells (Figure 6A). even in infants, contain higher levels of proinflammatory
cytokines, particularly IL-6 and IL-8, irrespective of bac-Indicative of viral production, HPIV3 NP was present in
untreated and control transfected cells but not in CF terial colonization (Aldallal et al., 2002; Noah et al., 1997).
Thus, it has been hypothesized that inflammation is in-cells expressing the NOS2 transgene. Quantitated as
nitrite and nitrate in the media, NO production in CF trinsic to the CF neonatal airway prior to infection. Here,
baseline IL-6 and IL-8 secretion are similar in CF andcells transfected with NOS2 transgene was similar to
Antiviral Host Defense and CF
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Figure 5. Activation and Expression of Transcription Factors in CF Cells
(A) WCE (4 g) from CF and NL cells, untreated or treated with TNF-, polyIC, or by IFN- for 3 hr were evaluated for IRF-1 by EMSA (n  4).
(B) NF-B activation was evaluated by EMSA in cells stimulated with TNF-, polyIC, or by IFN- for 1 hr (n  3).
(C) CF and NL cells were stimulated with IFN- for 30 min and WCE collected to evaluate for STAT1 activation by EMSA. IFN--stimulated
A549 was a positive control, and supershift with anti-STAT1 (p91) and competition with unlabeled GAS probe confirmed presence of STAT1
in the complex.
(D) STAT1 activation at different times was quantitated in four independent EMSA experiments, which were averaged and expressed as
relative units normalized to NL value at 2 hr.
(E) Cell lysate (20 g total protein/lane) from CF or NL 24 hr after IFN- stimulation was evaluated for STAT1 (p91) expression by Western
analysis. Lysates from 2fTGH and U3A were used as positive and negative controls.
(F) Quantitation of Western analysis of STAT1 expression in cell lysate from four pairs of NL and CF cells, unstimulated or 24 hr after IFN-.
NL, but IL-6 and IL-8 mRNA are higher, which may ac- creased cytokine production in CF airways. Taken to-
gether, the susceptibility of CF infants to virus may becount for the greater release of cytokines upon viral
infection. Thus, virus may be one stimulus for the in- explained by increased virus and cytokine production,
Immunity
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nevertheless rescued by pretreatment with IFN (Zhou et
al., 1999). Thus, virus-inducible, cell-autonomous innate
defenses are important to inhibiting virus, and indeed
may be crucial to host defense against viruses with
strategies that interfere with IFN signaling, such as
HPIV3.
STAT1 is required for IFN signal transduction in the
cell and essential for the survival response to virus infec-
tion (Durbin et al., 1996; Meraz et al., 1996). Despite
numerous downstream targets of STAT1 activation, loss
of NOS2 has been identified as a primary factor in the
susceptibility of STAT1 null animals to virus (Karupiah
et al., 1993). Although not clearly understood, decreased
STAT1 also produces a deficient antiviral state and loss
of NOS2, while other IFN-mediated genes respond nor-
mally (Briscoe et al., 1996; Karaghiosoff et al., 2000). In
two prior studies, nonfunctional JAK1 or Tyk2, receptor-
associated kinases in the IFN signaling pathway, re-
sulted in decreased STAT1 protein and activation, and
a defective antiviral state, although the response to
IFN- or -was intact (Briscoe et al., 1996; Karaghiosoff
et al., 2000). The Tyk2-deficient cells displayed a pheno-
type remarkably similar to the CF cells: increased virus
replication in cells, impairment of STAT1 activation, with
almost all IFN-dependent pathways intact except for
NOS2. Altogether, these and the present study suggest
that a threshold of STAT 1 may be required for the
antiviral state, expression of NOS2, and perhaps other
antiviral genes, such as 2, 5OAS. Alternatively, a JAK1-
Figure 6. NOS2 Overexpression or NO Donors Protect CF Cells from
or Tyk2-dependent signal may be required, in additionHPIV3 Infection
to STAT1, for expression of NOS2, and for the antiviral
(A) Western analysis for NOS2 and HPIV3 NP in CF cells infected
state (Briscoe et al., 1996).by HPIV3, transfected with NOS2 expression construct (NOS2,
Because IFN/STAT1 pathways are so effective in pre-pCCF37), exposed to reagent alone, or transfected with reverse
venting viral infection, many viruses have developedsequence NOS2 expression construct (R-NOS2, pCCF38) 24 hr prior
to infection (n  2). mechanisms to evade the interferon system of the host.
(B) Plaque assay using media overlying CF cells 24 hr after HPIV3 All members of the paramyxovirus family interfere with
infection (0.5 moi). 24 hr prior to infection, CF cells were transfected IFN signaling, although by different mechanisms (An-
with NOS2 expression construct (NOS2, pCCF37), reverse sequence
drejeva et al., 2002; Young et al., 2000). HPIV3 inhibitsNOS2 expression construct (R-NOS2, pCCF38), reagent alone (lipo-
IFN signaling, through specific reduction of serine phos-some), or left untreated. At the time of infection, some untreated CF
phorylation of STAT1 (Young et al., 2000). Serine phos-cells were exposed to NO donors, SNAP, or deta NONOate (detaNO).
Untreated cells have higher titer of infectious virus production than phorylation is intact in CF (data not shown), but CF cells
cells with NOS2-transgene or with NO donors [n  3, *p 
 0.02]. with impaired IFN activation of STAT1 may be particu-
larly vulnerable to serine phosphorylation block by
HPIV3, resulting in more effective interference with IFN
which results in greater airway inflammation and the signaling. While interference with IFN signaling is a com-
severe respiratory symptoms of CF infants with virus mon strategy by which paramyxovirus circumvents anti-
infection. viral defenses (Andrejeva et al., 2002; Young et al., 2000),
Despite defects in antiviral defenses, pretreatment viral proteins which block NOS pathways have not been
with IFNs protected CF from virus. The biologic conse- reported. Our data support that HPIV3 may not have
quences, including antiviral effects, of IFN are mediated specific strategies to escape NO effects. NO inhibits
by multiple independent genes. Induction of over 600 virus replication and even latency of virus, including
genes has been identified in response to IFNs (de Veer coxsackievirus, influenza A & B, murine cytomegalovi-
et al., 2001). Thus, it is difficult to assign IFN antiviral rus, vaccinia, ectromelia, and herpes simplex-1 (Croen,
action to any specific gene. Redundancy of antiviral 1993; Flodstrom et al., 2001; Karupiah et al., 1998; Karu-
defense is supported by the fact that pretreatment with piah and Harris, 1995; Rimmelzwaan et al., 1999; Saura
exogenous IFN leads to a protective antiviral state de- et al., 1999; Zaragoza et al., 1997). Here, HPIV3 is also
spite defects in various antiviral pathways. However, it shown to be inhibited by NO. Two specific virus targets
is clear that if the early antiviral defenses are lacking, of NO, ribonucleotide reductase and viral protease, have
using a strategy of knockout of specific antiviral genes, been suggested on the basis of in vitro exposure of viral
virus infection can lead to devastating effects despite protein to NO donors in cell free systems (Croen, 1993;
the presence of intact IFN pathways (Kosugi et al., 2002; Lepoivre et al., 1991; Saura et al., 1999). These two
Noda et al., 2001; Xiang et al., 2002; Zhou et al., 1999). known targets are absent in HPIV3. Although viral pro-
For example, mice deficient in Mx, RNase L, and PKR, teins may be targets of NO, NO also affects host pro-
teins, which is relevant to HPIV3 since it requires hostwhich are markedly susceptible to viral infections, are
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Plaque Assay and Immunofluorescent Stainingproteins for transcription and replication (De et al., 1993).
Culture supernatants were collected, and the yield of infectiousKnown targets for NO modification include thiol groups
HPIV3 in cells that underwent specific treatments was measured byand tyrosine, and NO may bind to heme iron in proteins
plaque assay on CV-1 cells as previously described (De et al., 1995).
(Grisham et al., 1999). In lung epithelial cells, over 40 24 hr postinfection, cells cultured on cover slides were stained for
cellular proteins are modified by tyrosine nitration, with HPIV3 by the method previously described (Choudhary et al., 2001).
consequences on activity and function (Aulak et al.,
2001). Tyrosine nitration is decreased by NOS inhibitors 35S-Methionine Labeling and Immunoprecipitation
and in NOS2 knockout cells; thus, NO modification of CF and NL cells in 12-well plate were infected with HPIV3 at 0.1
moi. At 12 hr postinfection, the medium was replaced with methio-both host and viral proteins and subsequent effects on
nine-free DMEM and incubation was continued in 37C. At 14 hrprotein expression and activity are also likely reduced
postinfection, the cells were labeled with 50 Ci of 35S-methioninein CF cells which lack NOS2.
in 1 ml methionine-free DMEM for 6 hr. Cells were washed with
It is interesting to speculate about whether CFTR has DPBS and cell lysates were prepared and 20 g of protein was
a direct effect or is a modifier gene for expression of immunoprecipitated by antibody against HPIV3 N-protein as pre-
STAT1, 2, 5OAS1, or NOS2. Inhibition of CFTR function viously described (De et al., 2000) and analyzed in an SDS-10%
polyacrylamide gel.results in reduced NOS2 mRNA in human tracheal epi-
thelial cell lines, while overexpression of human CFTR
IL-6 and IL-8 ELISAin CF mice intestinal epithelium leads to NOS2 expres-
Production of human IL-6 and IL-8 in the supernatant from CF andsion in the ileum (Steagall et al., 2000). These results
NL cells 24 hr after HPIV3 infection was evaluated using Quantikinesuggest that NOS2 expression may be directly related
human IL-6 and IL-8 ELISA (R&D Systems, Minneapolis, Minnesota).
to the presence of functional CFTR. In addition, the All samples were diluted ten times using appropriate calibration
present findings suggest that STAT1 and NOS2 may be buffer.
potential gene modifiers of the disease severity in CF
lung disease. An important component of the innate Custom cDNA Microarray and Affymetrix Gene Array
host defense in the airway is the ability of respiratory RNA extracted from CF and NL cells at baseline or after 8 hr IFN
treatment were evaluated for gene expression profile using custom-epithelial cells to produce NO continuously in vivo
constructed cDNA microarray as previously described (Frevel et al.,(Sanders et al., 1998). The continuous production of NO
2003). The ISG/AU/dsRNA array used in this study contains 1013in the airways is due in part to expression of NOS2 (Guo
ISGs, 1464 AU-rich genes, 18 genes potentially involved in AU di-et al., 1995). CF infants at birth prior to the onset of
rected mRNA decay, 54 ribosomal genes, 288 dsRNA-responsive
respiratory symptoms/infection have exhaled NO 3-fold genes, and 84 housekeeping genes (NOS2 is not on this array).
lower than in healthy controls, suggesting that the defect Affymetrix HG-U133A GeneChips were also used in this study to
evaluate baseline gene expression in CF and NL cells as previouslyin NOS2 expression occurs prior to onset of recurrent
described (Lipshutz et al., 1999; Yang et al., 2000).infections (Elphick et al., 2001). Here, NOS2 is conclu-
sively shown to be sufficient for antiviral defense in hu-
Western Analysisman airway epithelial cells. The success of overexpres-
Whole-cell lysates were prepared and Western analysis performedsion of NOS2 in CF cells, or pretreatment with IFN, in
as previously described (Uetani et al., 2000). The primary antibodiesprotection from viral infection indicates that these ap-
used included rabbit polyclonal antibody against NOS2 (Merck, Rah-
proaches are promising in prevention of CF lung infec- way, New Jersey), rabbit polyclonal antibody against C terminus
tion. Although less effective, provision of NO donors of IRF-1 (Santa Cruz Biotechnology, Santa Cruz, California), rabbit
provided significant reduction of viral production and polyclonal antibody against PKR (Carpick et al., 1997), mouse mono-
clonal antibody against RNase L (Dong and Silverman, 1995), rabbitmay be an alternative strategy for treatment of CF pa-
polyclonal antibodies against MxA and HPIV3 N-protein (Choudharytients.
et al., 2001), and rabbit polyclonal antibody against 2, 5 OAS1
(Ghosh et al., 2001).
Experimental Procedures
WCE and EMSACell Culture, Virus, and Cytokines
WCE were prepared and EMSA performed by methods previouslyHAEC were obtained through bronchoscopy brushing, from ex-
described (Guo et al., 1997; Uetani et al., 2000). To specificallyplanted lungs, or from segments of bronchus obtained from surgery
identify NF-B, IRF-1, and STAT1 (p91) proteins in binding com-and cultured by methods previously described (Guo et al., 2000;
plexes, 2–4 g of rabbit anti-p65, anti-p50, anti-IRF-1, or anti-Uetani et al., 2000). An aliquot of cultured cells was immunostained
STAT1 (p91) polyclonal Ab (Santa Cruz Biotechnology) was addedto confirm epithelial phenotype. In addition, all cells were genotyped
to the binding reaction mix and incubated for 30 min at room temper-for 86 common CFTR mutations by Genzyme Genetics (Boston,
ature before adding the 32P-labeled oligonucleotide.Massachusetts). All eight samples from explant CF lungs were con-
firmed to be homozygous F508/F508. Eleven samples from con-
trol non-CF lungs were all wild-type CFTR. NOS2 Expression Construct and Transient Transfection
A549 cells and CV-1 cells were maintained as previously de- Human NOS2 expression construct was made by inserting full-
scribed (Choudhary et al., 2001; Guo et al., 2000). HPIV3 (HA-1, NIH length NOS2 cDNA into a pAVS6 vector (Erzurum et al., 1993b). A
47885) was a kind gift from Dr. De. Human IFN- was a gift from control construct was also made by inserting reverse sequence
Genentech Inc. (South San Francisco, California). The IFN- was NOS2 cDNA into a pAVS6 vector. Transient transfection was per-
purchased from Sigma-Aldrich (St. Louis, Missouri). Recombinant formed on cells at 90% confluence using LipofectAMINE PLUS re-
human IL-1 and TNF- were from Genzyme. agent (Invitrogen Corporation, Carlsbad, California).
Nitrite and Nitrate QuantitationRNA Isolation and Northern Analysis
Total RNA was extracted by GTC-CsCl gradient method (Erzurum NO production was quantitated by measuring total nitrite and nitrate
in the media, using ISO-NO MarkII isolated nitric oxide meter andet al., 1993a). Northern analysis was carried out using 32P-dCTP-
labeled human NOS2 cDNA by methods previously described nitric oxide sensor (ISO-NOP) (World Precision Instruments, Inc.,
Sarasota, Florida). Data were collected and analyzed by Duo18.(Uetani et al., 2000).
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Statistical Analysis de Veer, M.J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape,
J.M., Silverman, R.H., and Williams, B.R. (2001). Functional classifi-The data are reported as means 	 standard deviation of the mean
(SD). Two-tailed t test statistics or the Mann-Whitney test was used cation of interferon-stimulated genes identified using microarrays.
J. Leukoc. Biol. 69, 912–920.as appropriate at a significance level of 0.05.
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